Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): GHRYVELIN (previously Macimorelin Aeterna Zentaris), macimorelin, Diagnostic Techniques, Endocrine, Date of authorisation: 11/01/2019, Revision: 3, Status: Authorised
TO: